From BIPA to GIPA: Another Four-Letter Word in Illinois Class Action Litigation, Part 1
ABSTRACT: A fresh wave of litigation has recently emerged in Illinois commonly known by the four-letter acronym GIPA—the Genetic Information Privacy Act. In a five-part series of posts, we examine GIPA’s background, key provisions of the Act, the remedies available under GIPA, certain types of GIPA cases being filed, and considerations for companies regarding GIPA litigation.
This week, Baker Sterchi is dedicating this blog to a discussion of the Genetic Information Privacy Act (‘GIPA”). In a five-part series of posts, we examine GIPA’s background, key provisions of the Act, the remedies available under GIPA, certain types of GIPA cases being filed, and considerations for companies regarding GIPA litigation.
Today, we examine the background of GIPA:
As discussed in prior Baker Sterchi blog posts, including here, here, and here, the Illinois Biometric Information Privacy Act (“BIPA”) has dominated the Illinois class action landscape for several years. There are no signs of BIPA litigation slowing down. Rather, five times as many BIPA lawsuits were filed in 2022 compared to 2018, and over 400 BIPA lawsuits were filed in Illinois in 2023.
There is another four-letter statute, however, of which companies doing business in Illinois should be aware: GIPA. GIPA, or the Genetic Information Privacy Act, was enacted in 1998. GIPA was amended in 2008, in part, to align with certain provisions of the federal Genetic Information Nondiscrimination Act of 2008. According to the legislative intent section of GIPA, many members of the public were deterred from seeking genetic testing because of fear that test results would be disclosed without consent in a manner not permitted by law or would be used in a discriminatory manner. Additionally, the legislature stated an intent that disclosure of genetic information required under the Health Insurance Portability and Accountability Act (“HIPPA”) be performed in accordance with HIPPA’s “minimum necessary standard.”
Until recently, few GIPA lawsuits were filed. According to our research, only two GIPA class action lawsuits were filed in 2021, and zero were filed in 2022. By contrast, 30 GIPA class action lawsuits were filed in 2023. What led to this surge in filings? Likely several factors, including the similarity of the right of action and remedy provisions in GIPA and BIPA, which we will further discuss later this week. Another likely factor is the recent approval of a class and subclass of plaintiffs in a GIPA suit by the District Court for the Northern District of Illinois. On August 3, 2023, the court granted the plaintiff’s motion for class certification in a case alleging that Sequencing, LLC violated GIPA by disclosing its customers’ genetic information to unknown third-party developers without first obtaining those customers’ consent. Melvin v. Sequencing, LLC, 344 F.R.D. 231 (N.D. Ill. 2023).
Tomorrow, we will examine GIPA’s key definitions and the Act’s confidentiality requirements. On Wednesday, we will evaluate the remedies available under GIPA. On Thursday, we will address GIPA lawsuits, focusing on those filed against insurers and employers, the types of defendants most frequently named in this litigation. Finally, on Friday, we will discuss considerations for defendants named in GIPA litigation and for companies doing business in Illinois.About Illinois Law Blog
Baker Sterchi's Illinois Law Blog examines significant developments, trends and changes in Illinois law on a broad range of topics that are of interest to Illinois practitioners and to businesses evaluating risks under Illinois law or managing litigation subject to Illinois law. Learn more about the editor, Lisa Larkin.
Subscribe via email
Subscribe to rss feeds
RSS FeedsABOUT baker sterchi blogs
Baker Sterchi Cowden & Rice LLC (Baker Sterchi) publishes this website as a service to our clients, colleagues and others, for informational purposes only. These materials are not intended to create an attorney-client relationship, and are not a substitute for sound legal advice. You should not base any action or lack of action on any information included in our website, without first seeking appropriate legal or other professional advice. If you contact us through our website or via email, no attorney-client relationship is created, and no confidential information should be transmitted. Communication with Baker Sterchi by e-mail or other transmissions over the Internet may not be secure, and you should not send confidential electronic messages that are not adequately encrypted.
The hiring of an attorney is an important decision, which should not be based solely on information appearing on our website. To the extent our website has provided links to other Internet resources, those links are not under our control, and we are not responsible for their content. We do our best to provide you current, accurate information; however, we cannot guarantee that this information is the most current, correct or complete. In addition, you should not take this information as a promise or indication of future results.
Disclaimer
The Illinois Law Blog is made available by Baker Sterchi Cowden & Rice LLC for educational purposes only as well as to give you general information and a general understanding of the law, not to provide specific legal advice. Your use of this blog site alone creates no attorney client relationship between you and the firm.
Confidential information
Do not include confidential information in comments or other feedback or messages related to the Illinois Law Blog, as these are neither confidential nor secure methods of communicating with attorneys. The Illinois Law Blog should not be used as a substitute for competent legal advice from a licensed professional attorney in your state.